LNTH - Lantheus Quarterly EPS earnings growth

Graphic logo of Lantheus Corp (LNTH)

High costs associated with AI diagnostics for cancer and heart disease are creating financial pressure, as illustrated by the quarterly growth in net earnings per share for Lantheus Holdings, Inc. (LNTH). The value -20.10 serves as the baseline parameter on this chart. Top imaging scientists ensure stability, while the robotization of isotope packaging minimizes costs and risks during drug production.

LNTH: Lantheus Quarterly EPS earnings growth 07/04/2022 - 11/18/2026

Lantheus Holdings, Inc. (LNTH) - metric breakdowns and financial figures

Summary company analytics:Lantheus Holdings, Inc.
Finished products of Lantheus Corp

This metric measures the rate of change in earnings per share, reflecting the efficiency of capital generation per quarter. The formula is sensitive to any deviations in operational reporting, which drives the market revaluation of the asset. By analyzing the relative quarterly change in EPS on GURU.Markets, an investor can track profit dynamics. For Lantheus Holdings, Inc. (LNTH), this growth is supported by the Pylarify monopoly and complex isotope logistics. Entry barriers ensure the stability of this indicator.

Analysis of competing companies

Regeneron Pharmaceuticals (REGN) - Year-over-year earnings per share growth for the last twelve months|IRTC: Year-over-year earnings per share growth rate for the last twelve months|MLYS (Mineralys Corp) - Quarterly EPS earnings growth|HeartFlow, Inc. - Year-over-year net earnings per share trend for the last twelve months|Year-over-year net earnings per share growth for the last 12 months KMTS (Kestra Medical)|ESPR - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth AMRN (Amarin Pharma)|Year-over-year earnings per share growth rate for the last twelve months AVR (Anteris Technologies Ltd)|Tenaya Therapeutics, Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months CVRx, Inc. CVRX|MIST (Milestone Pharmaceuticals Inc.) - Year-over-year net earnings per share growth for the last 12 months|Cardiol Therapeutics Inc - Year-over-year earnings per one share growth for the last 12 months|BEAT (HeartBeam Corporation) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Tenax Therapeutics Inc|Quarterly EPS earnings growth ADGM|BioCardia, Inc. - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth VTAK (Catheter Precision Inc)|ABIO - Year-over-year net earnings per share growth for the last 12 months|Acasti Pharma - Quarterly EPS earnings growth|AVTE - Quarterly EPS earnings growth|VERV (vervetx.com) - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share trend for the last twelve months WINT (Windtree Therapeutics Inc.)